Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ImClone Systems | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

ImClone Systems

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

John H. Johnson, formerly of Johnson & Johnson, has been named chief executive officer, ImClone Systems, effective August 27th. Mr. Johnson has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. He has held senior management positions of increasing responsibility at J&J and most recently served as company group chairman of its worldwide biopharmaceuticals unit, where he was responsible for the biotechnology, immunology and oncology commercial businesses, including Centocor, Ortho Biotech Products and the Worldwide Strategic Marketing Group.

“John has a strong track record in the biopharmaceutical industry and we are happy to have him serving as chief executive officer during this new era for ImClone,” said Alexander J. Denner, Ph.D., chairman of the executive committee of ImClone Systems.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters